Treatment for Presumed Ocular Histoplasmosis
NCT01790893
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Ocular Histoplasmosis
Interventions
DRUG:
aflibercept
Sponsor
John Kitchens, MD